Search

everythinglearnresearchcommunity

for

Search:↓

Hormones and neuroendocrine factors control hair growth and color, and more research could lead to new hair treatment options.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

Excessive hair growth can be assessed by history, exam, and blood tests, and treated with medication like dexamethasone, birth control pills, and spironolactone.

Different hair protein amounts change the strength of keratin/chitosan gels, useful for making predictable tissue engineering materials.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

PFS and PSSD are similar conditions with persistent sexual dysfunction after stopping medication.

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.

Some plants used in traditional medicine may help treat cancer because they contain proteins that can inactivate ribosomes.

Shorter daylight increases hair growth in Cashmere goats.

The French Endocrine Society suggests diagnosing PCOS with two of three signs, recommends lifestyle changes and clomiphene for treatment, and calls for more research on certain treatments and tests.

AGA patients have fewer hairs and smaller follicles; T:V ratio above 4:1 may indicate AGA.

Metformin and rosiglitazone both improved insulin use and hormonal symptoms in women with PCOS.

Some women with PCOS have CYP21 mutations and IRS1 variants, but these genetic factors are not major contributors to PCOS.

Finasteride treats enlarged prostate, improves urinary flow, but may cause sexual side effects.

Certain genetic variations in the SHBG gene are linked to an increased or decreased risk of PCOS in Mediterranean women.

Melatonin solution helps treat hair loss in men and women.

Hirsutism can be caused by various conditions besides PCOS, and it's important to treat the underlying issue and manage symptoms with medication and cosmetic approaches.

Raspberry ketone may help grow hair and improve skin elasticity.

Finasteride and CPA-EE2 equally reduce hirsutism, but affect hormone levels differently.

Some men with early hair loss may have a condition similar to PCOS in women.

Adrenal disorders can cause lasting brain and behavior issues in children.

Menopause-related hormonal changes affect hair but are not the only cause of hair changes in middle-aged women.

Weight loss and metformin don't significantly change vaspin levels in women with PCOS.

Women with only irregular periods or excess hair have a better hormone profile than those with full PCOS, but both groups are similar, indicating a need for better PCOS diagnosis methods.

A woman with breast cancer developed a rare condition causing excessive fine hair growth on her face and body.

Mice skin has components that could help with hair growth and might be used for diabetes treatment.

Hair problems are common and distressing for women, but increasing knowledge of treatments offers hope.